Another compounding trade group, the Alliance for Pharmacy Compounding, thanked the FDA for the grace period but insisted that the FDAs tirzepatide decision is not necessarily the end of the story. APC CEO Scott Brunner highlighted the ongoing litigation in a statement, writing that the agencys ruling was not a decision by a court. Its a unilateral action by the agency, so dont confuse the two, Brunner said, adding that he anticipated the court would also consider the perspective of compounders
Im very anxious to move probably not all of those peptides, some of them are in litigation but about 14 of them back to making them more accessible, Kennedy said, calling himself a big fan of peptides. Asprey has criticized the FDAs restrictions on compounding peptides and has applauded recent moves by the government to widen access to certain substances
For example, if nausea or other side effects cause the person to sweat more, this could worsen the discomfort of heat intolerance
This may be linked with a low level of Ca 2+ (Zhang et al., 2004
doi: 10.1038/s41419-018-0794-4